Clinical Feasibility and Safety of Scleral Collagen Cross-Linking by Riboflavin and Ultraviolet A in Pathological Myopia Blindness: A Pilot Study.
Yu LiYue QiMingshen SunChangbin ZhaiWenbin WeiFengju ZhangPublished in: Ophthalmology and therapy (2022)
Chinese Clinical Trial Registry (ChiCTR2100042422).